TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Tuesday reported a loss of $5.8 million in its first quarter.
On a per-share basis, the Toronto-based company said it had a loss of $4.74.
The drug developer posted revenue of $4,000 in the period.
Aeterna Zentaris shares have increased 13% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.39, a decline of 30% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AEZS at https://www.zacks.com/ap/AEZS
